APA (7th ed.) Citation

Raab, M., Thomas, S. K., Ocio, E. M., Guenther, A., Goh, Y., Talpaz, M., . . . Kumar, S. K. (2019). The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma. Leukemia, 33(12), . https://doi.org/10.1038/s41375-019-0482-0

Chicago Style (17th ed.) Citation

Raab, Marc-Steffen, et al. "The First-in-human Study of the Pan-PIM Kinase Inhibitor PIM447 in Patients with Relapsed And/or Refractory Multiple Myeloma." Leukemia 33, no. 12 (2019). https://doi.org/10.1038/s41375-019-0482-0.

MLA (9th ed.) Citation

Raab, Marc-Steffen, et al. "The First-in-human Study of the Pan-PIM Kinase Inhibitor PIM447 in Patients with Relapsed And/or Refractory Multiple Myeloma." Leukemia, vol. 33, no. 12, 2019, https://doi.org/10.1038/s41375-019-0482-0.